ATP acts as a neurotransmitter via seven P2X receptor-channels for Na+ and Ca2+, and eight G-protein-coupled P2Y receptors. Despite evidence suggesting roles in human heart, the map of myocardial P2 receptors is incomplete. and their involvement in chronic heart failure (CHF) has never received adequate attention. In left myocardia from five to nine control and 5-12 CHF subjects undergoing heart transplantation, we analyzed the full repertoire of P2 receptors and of 10"orphan" P2Y-like receptors. All known P2Y receptors (i.e. P2Y(1.1.4.6.11.12.13.14)) and two P2Y-like receptors (GPR91 and GPR17) were detected in all subjects. All known P2X(1-7), receptors were also detected: of these, only P2X(6) was upregulated in CHF, as confirmed by quantitative real time-PCR. The potential significance of this change was studied in primary cardiac fibroblasts freshly isolated from young pigs. Exposure of cardiac fibroblasts to ATP or its hydrolysis-resistant-analog benzoylATP induced apoptosis. TNF alpha (a cytokine implicated in CHF progression) exacerbated cell death. Similar effects were induced by ATP and TNF alpha in a murine cardiomyocytic cell line. In cardiac fibroblasts, TNF alpha inhibited the downregulation of P2X(6) MRNA associated to prolonged agonist exposure, suggesting that, by preventing ATP-induced P2X(6) desensitization. TNFa may abolish a defense mechanism meant at avoiding Ca2+ overload and, ultimately, Ca2+-dependent cell death. This may provide a basis for P2X(6) upregulation in CHF. In conclusion, we provide the first characterization of P2 receptors in the human heart and suggest that the interaction between TNF alpha and the upregulated P2X(6) receptor may represent a novel pathogenic mechanism in CHF. (c) 2005 Elsevier Ltd. All rights reserved.
Banfi, C., Ferrario, S., De Vincenti, O., Ceruti, S., Fumagalli, M., Mazzola, A., et al. (2005). P2 receptors in human heart: upregulation of P2X6 in patients undergoing heart transplantation, interaction with TNFalpha and potential role in myocardial cell death. JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY, 39(6), 929-939 [10.1016/j.yjmcc.2005.09.002].
P2 receptors in human heart: upregulation of P2X6 in patients undergoing heart transplantation, interaction with TNFalpha and potential role in myocardial cell death
D' Ambrosi, Nadia;
2005-12-01
Abstract
ATP acts as a neurotransmitter via seven P2X receptor-channels for Na+ and Ca2+, and eight G-protein-coupled P2Y receptors. Despite evidence suggesting roles in human heart, the map of myocardial P2 receptors is incomplete. and their involvement in chronic heart failure (CHF) has never received adequate attention. In left myocardia from five to nine control and 5-12 CHF subjects undergoing heart transplantation, we analyzed the full repertoire of P2 receptors and of 10"orphan" P2Y-like receptors. All known P2Y receptors (i.e. P2Y(1.1.4.6.11.12.13.14)) and two P2Y-like receptors (GPR91 and GPR17) were detected in all subjects. All known P2X(1-7), receptors were also detected: of these, only P2X(6) was upregulated in CHF, as confirmed by quantitative real time-PCR. The potential significance of this change was studied in primary cardiac fibroblasts freshly isolated from young pigs. Exposure of cardiac fibroblasts to ATP or its hydrolysis-resistant-analog benzoylATP induced apoptosis. TNF alpha (a cytokine implicated in CHF progression) exacerbated cell death. Similar effects were induced by ATP and TNF alpha in a murine cardiomyocytic cell line. In cardiac fibroblasts, TNF alpha inhibited the downregulation of P2X(6) MRNA associated to prolonged agonist exposure, suggesting that, by preventing ATP-induced P2X(6) desensitization. TNFa may abolish a defense mechanism meant at avoiding Ca2+ overload and, ultimately, Ca2+-dependent cell death. This may provide a basis for P2X(6) upregulation in CHF. In conclusion, we provide the first characterization of P2 receptors in the human heart and suggest that the interaction between TNF alpha and the upregulated P2X(6) receptor may represent a novel pathogenic mechanism in CHF. (c) 2005 Elsevier Ltd. All rights reserved.I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
